| Size & multiples | |||
| Market Cap | $262.8M | Enterprise Value | $291.9M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 3.07× | P/FCF | 137.59× |
| EV/EBITDA | 54.71× | EV/EBIT | — |
| EV/Sales | 3.41× | EV/FCF | 152.83× |
| FCF Yield | 0.73% | Buyback Yield | — |
| Owner Earnings (TTM) | -$5.5M | Owner Earnings Yield | −2.11% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.46 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 11.28% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −55.95% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted), Interest Expense · EPS TTM -$1.28 · revenue TTM $85.5M · FCF TTM $1.9M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | 2.1% | -7.8% | -34.7%–1.4% | 77 ↑strong |
| Net Margin | -65.5% | -21.2% | -325.3%–7.2% | 40 ↓weak |
| Operating Margin | -56.1% | -34.5% | -552.0%–8.0% | 45 ↓weak |
| ROE | -147.1% | -36.8% | -92.5%–4.5% | 15 ↓weak |
